Johnson & Johnson (JNJ)
146.14
-0.68
(-0.46%)
USD |
NYSE |
Apr 26, 16:00
146.05
-0.09
(-0.06%)
After-Hours: 20:00
Johnson & Johnson Gross Profit (TTM): 61.53B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 61.53B |
December 31, 2023 | 63.01B |
September 30, 2023 | 62.27B |
June 30, 2023 | 61.35B |
March 31, 2023 | 60.13B |
December 31, 2022 | 59.61B |
September 30, 2022 | 54.02B |
June 30, 2022 | 56.28B |
March 31, 2022 | 55.91B |
December 31, 2021 | 55.34B |
September 30, 2021 | 61.73B |
June 30, 2021 | 59.75B |
March 31, 2021 | 55.79B |
December 31, 2020 | 54.16B |
September 30, 2020 | 53.11B |
June 30, 2020 | 52.86B |
March 31, 2020 | 54.73B |
December 31, 2019 | 54.50B |
September 30, 2019 | 54.32B |
June 30, 2019 | 54.22B |
March 31, 2019 | 54.50B |
December 31, 2018 | 54.49B |
September 30, 2018 | 53.99B |
June 30, 2018 | 52.96B |
March 31, 2018 | 52.05B |
Date | Value |
---|---|
December 31, 2017 | 51.01B |
September 30, 2017 | 50.54B |
June 30, 2017 | 50.15B |
March 31, 2017 | 50.30B |
December 31, 2016 | 50.10B |
September 30, 2016 | 49.77B |
June 30, 2016 | 49.32B |
March 31, 2016 | 48.60B |
December 31, 2015 | 48.54B |
September 30, 2015 | 48.80B |
June 30, 2015 | 49.99B |
March 31, 2015 | 51.02B |
December 31, 2014 | 51.58B |
September 30, 2014 | 51.58B |
June 30, 2014 | 50.75B |
March 31, 2014 | 49.68B |
December 31, 2013 | 48.97B |
September 30, 2013 | 48.12B |
June 30, 2013 | 47.35B |
March 31, 2013 | 46.29B |
December 31, 2012 | 45.57B |
September 30, 2012 | 44.93B |
June 30, 2012 | 44.41B |
March 31, 2012 | 44.50B |
December 31, 2011 | 44.67B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
52.86B
Minimum
Jun 2020
63.01B
Maximum
Dec 2023
57.23B
Average
55.85B
Median
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Eli Lilly and Co | 27.04B |
Merck & Co Inc | 45.66B |
Pfizer Inc | 33.54B |
Shockwave Medical Inc | 634.84M |